Cargando…
Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase
The outbreak of SARS, a life-threatening disease, has spread over many countries around the world. So far there is no effective drug for the treatment of SARS. Stimulated by the binding mechanism of SARS-CoV M(pro) with the octapeptide AVLQSGFR reported recently as well as the “Chou's distorted...
Autores principales: | Gan, Yi-Ru, Huang, He, Huang, Yong-Dong, Rao, Chun-Ming, Zhao, Yang, Liu, Jin-Sheng, Wu, Lei, Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115688/ https://www.ncbi.nlm.nih.gov/pubmed/16242214 http://dx.doi.org/10.1016/j.peptides.2005.09.006 |
Ejemplares similares
-
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase()
por: Wei, Ping, et al.
Publicado: (2006) -
Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS()
por: Chou, Kuo-Chen, et al.
Publicado: (2003) -
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
por: Blanchard, Jan E., et al.
Publicado: (2004) -
Structure and Dynamics of Sars Coronavirus Main Proteinase (M(PRO))
por: Hilgenfeld, Rolf, et al.
Publicado: (2006) -
Enzymatic activity of the SARS coronavirus main proteinase dimer
por: Graziano, Vito, et al.
Publicado: (2006)